Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Sale |
2025-04-03 4:27 pm |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO & Chairman |
8,819 | $0.89 | $7,849 | 91,046 (Direct) |
View |
| 2024-04-02 Sale |
2024-04-03 5:23 pm |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO |
7,523 | $6.94 | $52,210 | 95,665 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Exercise |
2025-04-03 4:27 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO & Chairman |
25,000 | $0 | 91,046 (Direct) |
View |
| 2025-03-11 Option Award |
2025-03-17 4:24 pm |
N/A 2035-03-10 |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-03 8:58 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO |
1,710 | $4.45 | 22,375 (Direct) |
View |
| 2024-05-30 Option Award |
2024-05-31 4:15 pm |
N/A 2034-05-30 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 5:23 pm |
N/A N/A |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO |
25,000 | $0 | 95,665 (Direct) |
View |
| 2024-03-13 Option Award |
2024-03-15 08:30 am |
N/A 2034-03-12 |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO |
300,000 | $0 | 300,000 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-09 5:36 pm |
N/A 2033-06-08 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
13,000 | $0 | 13,000 (Direct) |
View |
| 2023-04-01 Option Award |
2023-04-04 4:05 pm |
N/A 2033-03-31 |
Inozyme Pharma Inc. | INZY | Treco Douglas A CEO |
900,000 | $0 | 900,000 (Direct) |
View |
| 2022-06-10 Option Award |
2022-06-14 07:52 am |
N/A 2032-06-09 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:44 pm |
N/A 2032-06-09 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-24 4:16 pm |
N/A 2031-06-22 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
9,367 | $0 | 9,367 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-14 5:39 pm |
N/A 2031-06-10 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2020-07-23 Option Award |
2020-07-24 4:50 pm |
N/A 2030-07-22 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
9,367 | $0 | 9,367 (Direct) |
View |
Ownership |
2020-07-23 9:21 pm |
N/A 2030-05-27 |
Inozyme Pharma Inc. | INZY | Treco Douglas A Director |
0 | $0 | 86,979 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-15 4:45 pm |
N/A 2030-06-11 |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
30,000 | $0 | 30,000 (Direct) |
View |
Ownership |
2020-06-15 4:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Treco Douglas A Director |
0 | $0 | 2,000 (Direct) |
View |